Two prognostic groups of inflammatory breast cancer have distinct genotypes

Clinical Cancer Research

Volumn 9, Issue 11, 2003, Pages 4184-4189

  Lerebours, Florence ^a,b,e   Bertheau, Philippe ^b   Bieche, Ivan ^a   Plassa, Louis François ^b   Champeme, Marie Helene ^a   Hacene, Kamel ^a   Toulas, Christine ^d   Espie, Marc ^b   Marty, Michel ^c   Lidereau, Rosette ^a  

^a INSERM   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d INSTITUT CLAUDIUS REGAUD   (France)

^e CENTRE RENÉ HUGUENIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MASTITIS; MUTATION; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

EID: 0141455132     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Chang, S., Parker, S. L., Pham, T., Buzdar, A. U., and Hursting, S. D. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992. Cancer (Phila.), 82: 2366-2372, 1998.
2. Jaiyesimi, I. A., Buzdar, A. U., and Hortobagyi, G. Inflammatory breast cancer: a review. J. Clin. Oncol., 10: 1014-1024, 1992.
3. Kleer, C. G., van Golen, K. L., and Merajver, S. D. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Res., 2: 423-429, 2000.
4. Lerebours, F., Bertheau, P., Bieche, I., Driouch, K., De The, H., Hacene, K., Espie, M., Marty, M., and Lidereau, R. Evidence of chromosome regions and gene involvement in inflammatory breast cancer. Int. J. Cancer, 102: 618-622, 2002.
5. Sarrazin, D., Rouesse, J., Arriagada, R., May-Levin, F., Petit, J. Y., and Contesso, G. Breast cancers in the evolutive phase. Rev. Prat., 28: 999-1009, 1978.
6. Bieche, I., Olivi, M., Champeme, M. H., Vidaud, D., Lidereau, R., and Vidaud, M. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int. J. Cancer, 78: 661-666, 1998.
7. Osborne, R. J., and Hamshere, M. G. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer. Cancer Res., 60: 3706-3712, 2000.
8. Pollack, J. R., Perou, C. M., Alizadeh, A. A., Eisen, M. B., Pergamenschikov, A., Williams, C. F., Jeffrey, S. S., Botstein, D., and Brown, P. O. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet., 23: 41-46, 1999.
9. Shen, C. Y., Yu, J. C., Lo, Y. L., Kuo, C. H., Yue, C. T., Jou, Y. S., Huang, C. S., Lung, J. C., and Wu, C. W. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res., 60: 3884-3892, 2000.
10. Driouch, K., Briffod, M., Bieche, I., Champeme, M. H., and Lidereau, R. Location of several putative genes possibly involved in human breast cancer progression. Cancer Res., 58: 2081-2086, 1998.
11. Iwase, H., Iwata, H., Toyama, T., Hara, Y., Omoto, Y., Ando, Y., Nakamura, T., and Kobayashi, S. The clinical value of microsatellite instability and a loss in heterozygosity in sporadic breast cancers. Breast Cancer, 4: 234-238, 1997.
12. Kerangueven, F., Noguchi, T., Coulier, F., Allione, F., Wargniez, V., Simony-Lafontaine, J., Longy, M., Jacquemier, J., Sobol, H., Eisinger, F., and Birnbaum, D. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res., 57: 5469-5474, 1997.
13. Chevallier, B., Asselain, B., Kunlin, A., Veyret, C., Bastit, P., and Graic, Y. Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis. Cancer (Phila.), 60: 897-902, 1987.
14. Palangie, T., Mosseri, V., Mihura, J., Campana, F., Beuzeboc, P., Dorval, T., Garcia-Giralt, E., Jouve, M., Scholl, S., Asselain, B., and Pouillart, P. Prognostic factors in inflammatory breast cancer and therapeutic implications. Eur. J. Cancer, 7: 921-927, 1994.
15. Rouesse, J., Friedman, S., Mouriesse, H., Sarrazin, D., and Spielmann, M. Therapeutic strategies in inflammatory breast carcinoma based on prognostic factors. Breast Cancer Res. Treat., 16: 15-22, 1990.
16. Adkins, D., Brown, R., Trinkaus, K., Maziarz, R., Luedke, S., Freytes, C., Needles, B., Wienski, D., Fracasso, P., Pluard, T., Moriconi, W., Ryan, T., Hoelzer, K., Safdar, S., Rearden, T., Rodriguez, G., Khoury, H., Vij, R., and DiPersio, J. Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer. J. Clin. Oncol., 17: 2006-2014, 1999.
17. Fleming, R. Y., Asmar, L., Buzdar, A. U., McNeese, M. D., Ames, F. C., Ross, M. I., and Singletary, S. E. Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma. Ann. Surg. Oncol., 4: 452-461, 1997.
18. Ueno, N. T., Buzdar, A. U., Singletary, S. E., Ames, F. C., McNeese, M. D., Holmes, F. A., Theriault, R. L., Strom, E. A., Wasaff, B. J., Asmar, L., Frye, D., and Hortobagyi, G. N. Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center. Cancer Chemother. Pharmacol., 40: 321-329, 1997.
19. Pollack, J. R., Sorlie, T., Perou, C. M., Rees, C. A., Jeffrey, S. S., Lonning, P. E., Tibshirani, R., Botstein, D., Borresen-Dale, A. L., and Brown, P. O. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. USA, 99: 12963-12968, 2002.
20. Emi, M., Yoshimoto, M., Sato, T., Matsumoto, S., Utada, Y., Ito, I., Minobe, K., Iwase, T., Katagiri, T., Bando, K., Akiyama, F., Harada, Y., Fukino, K., Sakamoto, G., Matsushima, M., Iida, A., Tada, T., Saito, H., Miki, Y., Kasumi, F., and Nakamura, Y. Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer. Genes Chromosomes Cancer, 26: 134-141, 1999.
21. Phelan, C. M., Borg, A., Cuny, M., Crichton, D. N., Baldersson, T., Andersen, T. I., Caligo, M. A., Lidereau, R., Lindblom, A., Seitz, S., Kelsell, D., Hamann, U., Rio, P., Thorlacius, S., Papp, J., Olah, E., Ponder, B., Bignon, Y. J., Scherneck, S., Barkardottir, R., Borresen-Dale, A. L., Eyfjord, J., Theillet, C., Thompson, A. M., and Larsson, C. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res., 58: 1004-1012, 1998.
22. Plummer, S. J., Paris, M. J., Myles, J., Tubbs, R., Crowe, J., and Casey, G. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors. Genes Chromosomes Cancer, 20: 354-362, 1997.
23. Cairns, P., and Sidransky, D. Molecular methods for the diagnosis of cancer. Biochim. Biophys. Acta, 1423: C11-C18, 1999.
24. Sasatomi, E., Finkelstein, S. D., Woods, J. D., Bakker, A., Swalsky, P. A., Luketich, J. D., Fernando, H. C., and Yousem, S. A. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value. Cancer Res., 62: 2681-2689, 2002.
25. Ueki, K., Nishikawa, R., Nakazato, Y., Hirose, T., Hirato, J., Funada, N., Fujimaki, T., Hojo, S., Kubo, O., Ide, T., Usui, M., Ochiai, C., Ito, S., Takahashi, H., Mukasa, A., Asai, A., and Kirino, T. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin. Cancer Res., 8: 196-201, 2002.